These results, together with a previous report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 help the notion of concentrating on ACKR3 as a unique method to modulate the opioid system, which could open up new therapeutic avenues for opioid-linked disorders. The dietary supplement is https://edwinsojyo.blogocial.com/about-conolidine-70059906